Invivo and iCAD Collaborate to Provide MRI Technology Worldwide

Invivo (Gainesville, FL, USA), a Philips Healthcare (Best, The Netherlands) business and a developer of magnetic resonance imaging (MRI) systems, and iCAD, Inc. (Nashua, NH, USA), a provider of imaging and radiation therapy technologies for the identification and treatment of cancer, reported that the companies have entered into a global research, development, and commercial agreement.

iCAD, under the agreement, will develop innovative MRI image analysis software products that Invivo will integrate into its range of MRI product solutions for global commercial sale. The first products are anticipated to be available in the second quarter of 2013. The first focus of the partnership will be the release of a next-generation platform for breast and prostate imaging. Additional new product releases are also expected beginning the second half of 2013.

This agreement allows iCAD and Invivo to continue bringing customers a comprehensive range of MR products including coils, accessories, and software, in combination with a world-class customer service and support organization.

“The collaboration with Invivo combines the strengths of two market leaders with synergistic technologies that will provide more robust product innovations, allowing us to further deliver on our mission to offer comprehensive imaging solutions that aid in the detection and treatment of cancer,” said Ken Ferry, CEO of iCAD. “As we continue to innovate and transform our business, we are now seeking to align the commercial strategy of our MR products similar to that of our successful mammography business.”

“iCAD’s MRI advanced image analysis products and technologies are a strong complement to Invivo’s market-leading breast and prostate clinical solutions,” said Brent Berthy, General Manager of Invivo. “Our new agreement with iCAD will allow us to further accelerate leading-edge innovation to our customers in this rapidly growing market segment.”

The DynaCAD 3.0 platform provides a feature-rich workspace allowing the user to manage data, generate analysis reports, and communicate results in a single solution. The quantitative and qualitative image analysis tools improve workflow effectiveness and provide improved flexibility for radiologists to quickly determine areas of concern for further assessment.

Invivo is a developer of radiofrequency (RF coils), image visualization systems, and MRI-compatible interventional instruments. Invivo is also a world leader in MRI patient vital signs monitoring. Invivo is also a leader in the MRI market, as well as its expanding businesses within the medical device sector.

iCAD is a leading provider of image analysis, workflow solutions and radiation therapies for the early identification and treatment of common cancers. iCAD provides a comprehensive range of high-performance, upgradeable computer-aided detection (CAD) systems for mammography and image analysis and workflow systems for MRI, for breast and prostate cancers and computed tomography (CT) for colorectal cancer. iCAD’s Xoft system provides radiation treatment for early-stage breast cancer that can be administered in the form of intraoperative radiation therapy or accelerated partial breast irradiation. The Xoft system is also cleared for the treatment of nonmelanoma skin cancer and endometrial cancer.

Related Links:
Invivo
iCAD